Experimental Coronavirus Treatment Trial Suspended By Chinese Researchers Due To Insufficient Patients

Because of the lack of adult patients with mild to moderate cases of COVID-19 for the clinical trials, a new report revealed that a team of experts in China suspended their research for the drug remdesivir, which is a potential COVID-19 treatment.
Read Original Article: Experimental Coronavirus Treatment Trial Suspended By Chinese Researchers Due To Insufficient Patients »